P. Saltel

758 total citations
41 papers, 550 citations indexed

About

P. Saltel is a scholar working on Oncology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P. Saltel has authored 41 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in General Health Professions and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P. Saltel's work include Cancer survivorship and care (16 papers), Health, Medicine and Society (16 papers) and Palliative Care and End-of-Life Issues (15 papers). P. Saltel is often cited by papers focused on Cancer survivorship and care (16 papers), Health, Medicine and Society (16 papers) and Palliative Care and End-of-Life Issues (15 papers). P. Saltel collaborates with scholars based in France, Luxembourg and United States. P. Saltel's co-authors include Annie Gauvain‐Piquard, Bernard Desclaux, Paul Dickès, Sylvie Dolbeault, P. Hardy, A. Brédart, Gilles Freyer, Françoise Desseigne, Valérie Bonadona and Olga M. Sinilnikova and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Acta Psychiatrica Scandinavica.

In The Last Decade

P. Saltel

37 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Saltel France 10 289 167 157 133 107 41 550
Hitoshi Okamura Japan 7 467 1.6× 232 1.4× 147 0.9× 148 1.1× 75 0.7× 9 649
Chiewkwei Kaw United States 8 417 1.4× 235 1.4× 165 1.1× 119 0.9× 61 0.6× 9 720
Jennifer A. Hansen United States 7 543 1.9× 335 2.0× 133 0.8× 252 1.9× 91 0.9× 7 867
Nellie Garcia United States 7 567 2.0× 262 1.6× 186 1.2× 155 1.2× 157 1.5× 11 782
Yasmin Asvat United States 11 187 0.6× 71 0.4× 82 0.5× 172 1.3× 96 0.9× 16 507
Barbara France United Kingdom 8 292 1.0× 94 0.6× 252 1.6× 54 0.4× 176 1.6× 8 673
A. Cooper United States 10 357 1.2× 211 1.3× 223 1.4× 81 0.6× 56 0.5× 20 709
Susanne Maislinger Austria 4 370 1.3× 234 1.4× 206 1.3× 57 0.4× 159 1.5× 5 642
Carriene Roorda Netherlands 9 385 1.3× 119 0.7× 123 0.8× 133 1.0× 82 0.8× 9 508
Jennifer Finnegan-John United Kingdom 9 264 0.9× 90 0.5× 81 0.5× 89 0.7× 93 0.9× 18 626

Countries citing papers authored by P. Saltel

Since Specialization
Citations

This map shows the geographic impact of P. Saltel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Saltel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Saltel more than expected).

Fields of papers citing papers by P. Saltel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Saltel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Saltel. The network helps show where P. Saltel may publish in the future.

Co-authorship network of co-authors of P. Saltel

This figure shows the co-authorship network connecting the top 25 collaborators of P. Saltel. A scholar is included among the top collaborators of P. Saltel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Saltel. P. Saltel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chvetzoff, Gisèle, Carole Bouleuc, Audrey Lardy-Cléaud, et al.. (2022). Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS. Supportive Care in Cancer. 31(1). 82–82. 5 indexed citations
2.
Trédan, Olivier, et al.. (2015). Prevalence of depressive syndrome in patients with breast cancer treated with or without aromatase inhibitors. ONCOLOGIE. 17(11-12). 587–594. 1 indexed citations
3.
Lerebours, Florence, et al.. (2015). Satisfaction des patientes traitées par chimiothérapie en hôpital de jour pour un cancer du sein : résultats de l’enquête TemporELLES. Bulletin du Cancer. 102(4). 316–323. 7 indexed citations
4.
Falandry, Claire, Wadih Rhondali, Gilles Freyer, et al.. (2015). Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer. Clinical Interventions in Aging. 10. 1155–1155. 16 indexed citations
5.
Desseigne, Françoise, et al.. (2014). Prodromal depression in pancreatic cancer: Retrospective evaluation on ten patients. Palliative & Supportive Care. 13(3). 801–807. 7 indexed citations
6.
Rhondali, Wadih, P. Saltel, V. Trillet-Lenoir, et al.. (2012). Depression assessment by oncologists and palliative care physicians. Palliative & Supportive Care. 10(4). 255–263. 10 indexed citations
7.
Rhondali, Wadih, Julien Berthiller, P. Saltel, et al.. (2012). Frequency of depression among oncology outpatients and association with other symptoms. Supportive Care in Cancer. 20(11). 2795–2802. 41 indexed citations
8.
Rhondali, Wadih, et al.. (2011). Validation linguistique et métrique de la version française de la Brief Edinburgh Depression Scale (BEDS). Bulletin du Cancer. 98(2). 199–208. 5 indexed citations
9.
Saltel, P.. (2009). Psycho-oncologie et soins de support: l'expérience du psychiatre. Bulletin du Cancer. 96(spec2). 91–97.
10.
11.
Chvetzoff, Gisèle, et al.. (2006). Étude prospective de qualité des soins et de qualité de vie chez des patients cancéreux en phase palliative, en hospitalisation ou à domicile : analyse intermédiaire de l’étude Trapado. Bulletin du Cancer. 93(2). 213–221. 7 indexed citations
12.
Saltel, P., et al.. (2004). How to Improve the Relationship with the Patient in Hematology-Oncology?. 19(1). 3–8. 2 indexed citations
13.
Bonadona, Valérie, P. Saltel, Françoise Desseigne, et al.. (2002). Cancer Patients Who Experienced Diagnostic Genetic Testing for Cancer Susceptibility. Cancer Epidemiology and Prevention Biomarkers. 11(1). 97–104. 1 indexed citations
14.
Saltel, P.. (2002). Psycho-oncologie : méthodes, outils. Cancer/Radiothérapie. 6. 207–213. 2 indexed citations
15.
Bonadona, Valérie, P. Saltel, Françoise Desseigne, et al.. (2002). Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.. PubMed. 11(1). 97–104. 89 indexed citations
16.
Saltel, P., et al.. (2001). L’information de la famille d’un patient adulte atteint de cancer. Bulletin du Cancer. 88(4). 399–405. 12 indexed citations
17.
Razavi, Darius, J.‐F. Allilaire, Mark A. Smith, et al.. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica. 94(3). 205–210. 128 indexed citations
18.
Merrouche, Yacine, Gilles Freyer, P. Saltel, & Paul Rebattu. (1996). Quality of final care for terminal cancer patients in a comprehensive cancer centre from the point of view of patients' families. Supportive Care in Cancer. 4(3). 163–168. 17 indexed citations
19.
Saltel, P., et al.. (1995). Standards, options et recommandations pour une bonne pratique en psycho-oncologie. Bulletin du Cancer. 10(10). 847–864. 5 indexed citations
20.
Négrier, Sylvie, et al.. (1995). Evaluation of the informed consent procedure in cancer patients candidate to immunotherapy. European Journal of Cancer. 31(10). 1650–1652. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitoshi Okamura Breakdown of academic impact, for papers by Chiewkwei Kaw Breakdown of academic impact, for papers by Jennifer A. Hansen Breakdown of academic impact, for papers by Nellie Garcia Breakdown of academic impact, for papers by Yasmin Asvat Breakdown of academic impact, for papers by Barbara France Breakdown of academic impact, for papers by A. Cooper Breakdown of academic impact, for papers by Susanne Maislinger Breakdown of academic impact, for papers by Carriene Roorda Breakdown of academic impact, for papers by Jennifer Finnegan-John
Rankless by CCL
2026